Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

146 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Completed

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

NCT02752035

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Hematologic Diseases, +6 more
Locations
  • UCLA David Geffen School of Medicine Los Angeles, California, United States
  • University of California, Irvine Medical Center Orange, California, United States
  • Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 111 locations
View Trial Details
Completed

A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

NCT04102020

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Mitchell Cancer Institute /ID# 216443 Mobile, Alabama, United States
  • Compassionate Cancer Care Research Group - Fountain Valley /ID# 216156 Fountain Valley, California, United States
  • University of California, Los Angeles /ID# 219149 Los Angeles, California, United States
  • Colorado Blood Cancer Institute /ID# 214280 Denver, Colorado, United States
View all 156 locations
View Trial Details
Completed

A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

NCT05665530

Conditions
Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Bone Marrow Diseases, +41 more
Locations
  • City of Hope Duarte, California, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
View all 24 locations
View Trial Details
Completed

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

NCT04826523

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Pusan National University Hospital /ID# 239010 Busan, Busan Gwang Yeogsi, South Korea
  • Kosin University Gospel Hospital /ID# 257399 Busan, Busan Gwang Yeogsi, South Korea
  • Kyungpook National University Hospital /ID# 257398 Daegu, Daegu Gwang Yeogsi, South Korea
  • Gachon University Gil Medical Center /ID# 239008 Incheon, Gyeonggido, South Korea
View Trial Details
Completed

VYxeoS Liposomal Italian Observational Study iN the Real Practice

NCT06143839

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Hematologic Diseases, +7 more
Locations
  • Azienda ospedaliera Santi Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Ospedale Papa Giovanni XXIII Bergamo, Italy
  • Policlinico Sant'Orsola Bologna, Italy
  • Ospedale di Bolzano Bolzano, Italy
View all 24 locations
View Trial Details
Completed

A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy

NCT04266795

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View all 57 locations
View Trial Details
Completed

A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

NCT03069352

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • H. Lee Moffit Cancer Center /ID# 164273 Tampa, Florida, United States
  • Norton Cancer Institute /ID# 158998 Louisville, Kentucky, United States
  • Univ of Pittsburgh Med Ctr /ID# 158997 Pittsburgh, Pennsylvania, United States
  • Univ TX, MD Anderson /ID# 159678 Houston, Texas, United States
View all 109 locations
View Trial Details

Related conditions